LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Search

Insulet Corp

Cerrado

SectorSanidad

144.75 1.41

Resumen

Variación precio

24h

Actual

Mínimo

141.49

Máximo

144.77

Métricas clave

By Trading Economics

Ingresos

-11M

91M

Ventas

-22M

762M

P/B

Media del Sector

36.269

50.102

BPA

1.3

Margen de beneficios

11.96

Empleados

5,400

EBITDA

-23M

154M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+60.9% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.1B

11B

Apertura anterior

143.34

Cierre anterior

144.75

Noticias sobre sentimiento de mercado

By Acuity

46%

54%

143 / 344 Clasificación en Healthcare

Insulet Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 may 2026, 19:47 UTC

Ganancias

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

Comparación entre iguales

Cambio de precio

Insulet Corp previsión

Precio Objetivo

By TipRanks

60.9% repunte

Estimación a 12 Meses

Media 229.53 USD  60.9%

Máximo 294 USD

Mínimo 154 USD

De acuerdo con 21 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Insulet Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

21 ratings

17

Comprar

3

Mantener

1

Vender

Sentimiento

By Acuity

143 / 344 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat